Ukrainian veterinary biopharmaceutical company BIOTESTLAB is set to mark a significant milestone in its global roadmap by debuting at The International Production & Processing Expo (2026 IPPE) in Atlanta, USA. The company will showcase its range of vaccines and therapeutic solutions for animal health, demonstrating the strength of its R&D and manufacturing capabilities, as well as partnership opportunities.
Expanding Global Presence
BIOTESTLAB's products are available in over 20 countries, and the company continues to broaden its international footprint.
Registration procedures are ongoing in 21 countries, with 93 dossiers submitted to regulatory authorities. These figures reflect BIOTESTLAB's steady growth in the veterinary drug market and its increasing international collaboration.
Product Portfolio and Key Focus Areas
At Booth #A2950, BIOTESTLAB will showcase a comprehensive portfolio of vaccines for poultry, swine, cattle, and rabbits, complemented by a wide range of therapeutic solutions for food-producing and companion animals.
Visitors will have the opportunity to explore the company’s latest advancements, including Floxy-Spray — a cutting-edge alternative to traditional topical treatments — alongside a robust pipeline of proprietary formulations and high-quality generic medicines.
New Biopharmaceutical Research and Production Complex
BIOTESTLAB will also highlight its new biopharmaceutical research and production complex in Ukraine. The facility is designed and certified according to GMP standards, ensuring high quality, reliability, and flexible production capabilities. EU GMP certification is anticipated.
The complex is intended for the development and manufacturing of veterinary immunobiological and pharmaceutical products and is a key part of the company's strategy to strengthen its manufacturing capacity.
Partnership Initiatives for the USA and LATAM
BIOTESTLAB views 2026 IPPE as a strategic gateway to expanding its collaboration in the USA and LATAM.
The company's goal is to forge long-term partnerships that establish a robust local presence and foster joint product development.
The company invites the following to collaborate:
• Distribution Networks: Companies operating in the veterinary pharmaceuticals market are looking for high-quality, reliable products.
• Scientific & Manufacturing Partners: Diagnostic centres and facilities interested in joint ventures for autogenous vaccines, contract manufacturing, technical support, and potential acquisitions.
• Industry Specialists: Top-tier talent in animal health ready to join our team and drive expansion within the USA and LATAM markets.
Strategic Positioning
Oleg Hrodzevich, CEO of BIOTESTLAB:
"BIOTESTLAB is actively strengthening its position in the international market. We are investing in new products, technologies, expanding production capacity, and creating partnerships that facilitate access to high-quality veterinary solutions worldwide."
Andrii Sobko, Business Development Director of BIOTESTLAB:
"We view 2026 IPPE as a strategic platform for developing collaboration in the USA and LATAM countries. Our goal is to ensure BIOTESTLAB's effective presence in the region and offer highly in-demand animal health solutions. We look forward to connecting and transforming in-person discussions into long-term, value-driven partnerships."
About BIOTESTLAB
BIOTESTLAB is a veterinary biopharmaceutical company committed to innovative products for animal and poultry health, improving the impact on human health and the environment. With a growing presence in international markets, we are driven by our mission to drive high-quality veterinary vaccines and medicines worldwide.
Visit BIOTESTLAB at the 2026 IPPE
Booth #A2950 in A Hall of the Georgia World Congress Center
January 27–29, 2026 | Atlanta, USA
More Information
• Product Catalogue: For detailed information on BIOTESTLAB's comprehensive product offerings, please visit: www.biotestlab.ua/en/catalogs
• Partnership Inquiries: To discuss collaboration opportunities or schedule a meeting, please get in touch with Andrii Sobko, Business Development Director: a.sobko@btl.vet
• Media Contact: For press inquiries, please get in touch with Alla Kharchenko: a_kharchenko@biotestlab.ua
Speak with our team or submit your interest via the BIOTESTLAB Contact Form